Dr. Erik D. Bernstein, MD
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Medical school
- Drexel University College of Medicine (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 467
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: Drexel University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
GA license 58851 -
Internal Medicine Physician
GA license 58851
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Candler Hospital Savannah, GA
- St Joseph's Hospital - Savannah Savannah, GA
- Savannah Health Services LLC DBA Memorial Health University Medical Center Savannah, GA
- Effingham Health System Springfield, GA
Medical groups
- Nephrology and Hypertension Medical Associates PC (19 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 467
- Services billed
- 2,076
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 577 | 149 |
| Established patient office or other outpatient visit, 30-39 minutes | 425 | 228 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 225 | 78 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 119 | 106 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 106 | 27 |
| Hemodialysis procedure with physician evaluation | 102 | 53 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 69 | 23 |
| Dialysis procedure including 1 evaluation | 24 | 12 |
| Established patient office or other outpatient visit, 20-29 minutes | 19 | 19 |
| Established patient office or other outpatient visit, 40-54 minutes | 16 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Calcitriol Other prescribers in Savannah, GA | 322 |
| Amlodipine Besylate Other prescribers in Savannah, GA | 251 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Savannah, GA | 175 |
| Losartan Potassium Other prescribers in Savannah, GA | 173 |
| Furosemide Other prescribers in Savannah, GA | 155 |
| Carvedilol Other prescribers in Savannah, GA | 129 |
| Ciprofloxacin Hcl Other prescribers in Savannah, GA | 77 |
| Febuxostat Other prescribers in Savannah, GA | 77 |
| Chlorthalidone Other prescribers in Savannah, GA | 73 |
| Nifedipine Er (nifedipine) Other prescribers in Savannah, GA | 67 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 37 payments worth $803 in total to this clinician.
| Amgen Inc. | $119 |
|---|---|
| Mallinckrodt Hospital Products Inc. | $116 |
| Averitas Pharma Inc. | $88.72 |
| Ardelyx, Inc. | $81.63 |
| Calliditas Therapeutics US Inc. | $55.42 |
| Travere Therapeutics, Inc. | $49.44 |
| Otsuka America Pharmaceutical, Inc. | $47.29 |
| Bayer HealthCare Pharmaceuticals Inc. | $34.04 |
| Food and Beverage | $799 |
|---|---|
| Education | $4.43 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Travere Therapeutics, Inc. Jun 5, 2025 | Education Filspari · Kidney Disease · in-kind | $2.38 |
| Travere Therapeutics, Inc. Jun 5, 2025 | Education Filspari · Kidney Disease · in-kind | $1.66 |
| Travere Therapeutics, Inc. Dec 4, 2025 | Education Filspari · Kidney Disease · in-kind | $0.39 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.